Header Logo

Connection

Meenakshi Jolly to Female

Back to Details
This is a "connection" page, showing publications Meenakshi Jolly has written about Female.
Meenakshi Jolly
Connection Strength
1.809
Female
  1. Pneumococcal Vaccination Among Lupus Patients: Who Are the Recipients? J Clin Rheumatol. 2021 Dec 01; 27(8):e456-e461.
    View in: PubMed
    Score: 0.062
  2. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.
    View in: PubMed
    Score: 0.061
  3. Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus. Arthritis Care Res (Hoboken). 2019 03; 71(3):406-412.
    View in: PubMed
    Score: 0.051
  4. Fatigue in systemic lupus: the role of disease activity and its correlates. Lupus. 2019 Feb; 28(2):163-173.
    View in: PubMed
    Score: 0.051
  5. Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2019 12; 71(12):1647-1652.
    View in: PubMed
    Score: 0.051
  6. Does Systemic Lupus Erythematosus Care Provided in a Lupus Clinic Result in Higher Quality of Care Than That Provided in a General Rheumatology Clinic? Arthritis Care Res (Hoboken). 2018 12; 70(12):1771-1777.
    View in: PubMed
    Score: 0.051
  7. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus. Lupus. 2018 Apr; 27(5):728-737.
    View in: PubMed
    Score: 0.047
  8. Disease-specific quality of life in patients with lupus nephritis. Lupus. 2018 Feb; 27(2):257-264.
    View in: PubMed
    Score: 0.046
  9. Practice patterns in longitudinal lupus care provision: patient and physician perspectives. Lupus. 2017 Dec; 26(14):1556-1561.
    View in: PubMed
    Score: 0.046
  10. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index. Lupus. 2017 Apr; 26(4):396-402.
    View in: PubMed
    Score: 0.044
  11. Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2016 06; 68(6):1422-31.
    View in: PubMed
    Score: 0.043
  12. Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels. Lupus. 2016 Jun; 25(7):735-40.
    View in: PubMed
    Score: 0.042
  13. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus. Lupus. 2015 Dec; 24(14):1486-91.
    View in: PubMed
    Score: 0.040
  14. Caregiving, dyadic quality of life and dyadic relationships in lupus. Lupus. 2015 Aug; 24(9):918-26.
    View in: PubMed
    Score: 0.039
  15. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 Feb; 67(2):297-304.
    View in: PubMed
    Score: 0.039
  16. Body image intervention to improve health outcomes in lupus: a pilot study. J Clin Rheumatol. 2014 Dec; 20(8):403-10.
    View in: PubMed
    Score: 0.038
  17. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2014 Oct; 66(10):1542-50.
    View in: PubMed
    Score: 0.038
  18. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus. Lupus. 2014 Dec; 23(14):1452-9.
    View in: PubMed
    Score: 0.038
  19. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus. Lupus. 2014 Aug; 23(9):881-8.
    View in: PubMed
    Score: 0.037
  20. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013 Sep; 19(6):334-40.
    View in: PubMed
    Score: 0.035
  21. Turkish lupusPRO: cross-cultural validation study for lupus. Clin Rheumatol. 2014 Aug; 33(8):1079-84.
    View in: PubMed
    Score: 0.035
  22. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol. 2013 Aug; 40(8):1327-33.
    View in: PubMed
    Score: 0.035
  23. Spanish LupusPRO: cross-cultural validation study for lupus. Lupus. 2013 Apr; 22(5):431-6.
    View in: PubMed
    Score: 0.034
  24. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines. Lupus. 2013 Mar; 22(3):262-7.
    View in: PubMed
    Score: 0.034
  25. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures. J Am Acad Dermatol. 2013 Apr; 68(4):618-623.
    View in: PubMed
    Score: 0.033
  26. Rheumatologists' quality of care for lupus: comparison study between a university and county hospital. Arthritis Care Res (Hoboken). 2012 Aug; 64(8):1261-4.
    View in: PubMed
    Score: 0.033
  27. Body image in patients with systemic lupus erythematosus. Int J Behav Med. 2012 Jun; 19(2):157-64.
    View in: PubMed
    Score: 0.032
  28. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 Aug; 42(1):56-65.
    View in: PubMed
    Score: 0.032
  29. A brief assessment tool for body image in systemic lupus erythematosus. Body Image. 2012 Mar; 9(2):279-84.
    View in: PubMed
    Score: 0.031
  30. Treatment of lupus: impact on quality of life. Curr Rheumatol Rep. 2011 Aug; 13(4):324-37.
    View in: PubMed
    Score: 0.031
  31. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Arthritis Care Res (Hoboken). 2011 Jun; 63(6):891-8.
    View in: PubMed
    Score: 0.030
  32. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol. 2010 Sep; 37(9):1828-33.
    View in: PubMed
    Score: 0.029
  33. Education, zip code-based annualized household income, and health outcomes in patients with systemic lupus erythematosus. J Rheumatol. 2010 Jun; 37(6):1150-7.
    View in: PubMed
    Score: 0.028
  34. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis. 2010 Jan; 69(1):29-33.
    View in: PubMed
    Score: 0.027
  35. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009 Jun; 36(6):1209-16.
    View in: PubMed
    Score: 0.026
  36. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus. Arthritis Rheum. 2007 Mar 15; 57(2):352-4.
    View in: PubMed
    Score: 0.023
  37. Tattoo: inflicted vasculitis? J Clin Rheumatol. 2007 Feb; 13(1):49.
    View in: PubMed
    Score: 0.022
  38. Looking beyond the ordinary: genital lupus. Arthritis Rheum. 2006 Oct 15; 55(5):821-2.
    View in: PubMed
    Score: 0.022
  39. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005 Sep; 32(9):1706-8.
    View in: PubMed
    Score: 0.020
  40. Discoid lupus erythematosus after tattoo: Koebner phenomenon. Arthritis Rheum. 2005 Aug 15; 53(4):627.
    View in: PubMed
    Score: 0.020
  41. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis. J Clin Rheumatol. 2005 Aug; 11(4):213-5.
    View in: PubMed
    Score: 0.020
  42. The risk of cardiac events among patients with systemic lupus erythematosus: comment on the article by Costenbader et al. Arthritis Rheum. 2005 Jun 15; 53(3):476.
    View in: PubMed
    Score: 0.020
  43. Association of rheumatologic disease with preeclampsia. Obstet Gynecol. 2004 Nov; 104(5 Pt 1):1105-6; author reply 1106.
    View in: PubMed
    Score: 0.019
  44. Chlamydial infection preceding the development of rheumatoid arthritis: a brief report. Clin Rheumatol. 2004 Oct; 23(5):453-5.
    View in: PubMed
    Score: 0.019
  45. Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus. Lupus. 2004; 13(1):64-9.
    View in: PubMed
    Score: 0.018
  46. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus. 2004; 13(12):924-6.
    View in: PubMed
    Score: 0.018
  47. Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus. Lupus. 2022 Oct; 31(12):1498-1507.
    View in: PubMed
    Score: 0.016
  48. Fatigue and its correlates in Indian patients with systemic lupus erythematosus. Clin Rheumatol. 2021 Mar; 40(3):905-911.
    View in: PubMed
    Score: 0.014
  49. Longitudinal Study of Fatigue, Stress, and Depression: Role of Reduction in Stress Toward Improvement in Fatigue. Arthritis Care Res (Hoboken). 2020 10; 72(10):1440-1448.
    View in: PubMed
    Score: 0.014
  50. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients. Lupus. 2020 Nov; 29(13):1727-1735.
    View in: PubMed
    Score: 0.014
  51. Performance and psychometric properties of lupus impact tracker in assessing patient-reported outcomes in pediatric lupus: Report from a pilot study. Lupus. 2020 Nov; 29(13):1781-1789.
    View in: PubMed
    Score: 0.014
  52. Patient-Reported Outcomes Predict Mortality in Lupus. Arthritis Care Res (Hoboken). 2019 08; 71(8):1028-1035.
    View in: PubMed
    Score: 0.013
  53. Validation of SIMPLE Index for Lupus Disease Activity. J Clin Rheumatol. 2018 Sep; 24(6):313-318.
    View in: PubMed
    Score: 0.012
  54. Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus. Mol Med. 2018 06 01; 24(1):24.
    View in: PubMed
    Score: 0.012
  55. External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017 06; 69(6):842-848.
    View in: PubMed
    Score: 0.011
  56. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017 Apr 03; 127(4):1271-1283.
    View in: PubMed
    Score: 0.011
  57. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus. Lupus. 2017 Aug; 26(9):967-974.
    View in: PubMed
    Score: 0.011
  58. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus. Lupus. 2017 Jul; 26(8):849-856.
    View in: PubMed
    Score: 0.011
  59. Validation of the Lupus Impact Tracker in an Australian patient cohort. Lupus. 2017 Jan; 26(1):98-105.
    View in: PubMed
    Score: 0.011
  60. Pain and depression predict self-reported fatigue/energy in lupus. Lupus. 2013 Jun; 22(7):684-9.
    View in: PubMed
    Score: 0.009
  61. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:802581.
    View in: PubMed
    Score: 0.008
  62. The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus. 2011 Oct; 20(12):1285-92.
    View in: PubMed
    Score: 0.008
  63. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011 Apr; 63(4):1044-53.
    View in: PubMed
    Score: 0.007
  64. Depression predicts self-reported disease activity in systemic lupus erythematosus. Lupus. 2011 Jan; 20(1):80-4.
    View in: PubMed
    Score: 0.007
  65. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010 Aug; 12(4):237-49.
    View in: PubMed
    Score: 0.007
  66. Patient reported outcomes and analgesia use in osteoarthritis of the knee. Osteoarthritis Cartilage. 2008 Nov; 16(11):1294-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.